DI LUCA, MARIAGRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 4.148
AS - Asia 2.277
EU - Europa 1.766
SA - Sud America 523
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 8.828
Nazione #
US - Stati Uniti d'America 4.045
IT - Italia 770
SG - Singapore 710
CN - Cina 665
BR - Brasile 425
HK - Hong Kong 389
SE - Svezia 223
DE - Germania 168
VN - Vietnam 165
BG - Bulgaria 137
GB - Regno Unito 82
RU - Federazione Russa 79
IN - India 66
FR - Francia 64
TR - Turchia 64
AT - Austria 62
CA - Canada 62
KR - Corea 62
FI - Finlandia 61
AR - Argentina 42
SN - Senegal 33
JP - Giappone 30
PK - Pakistan 29
BE - Belgio 23
CI - Costa d'Avorio 23
BD - Bangladesh 18
MX - Messico 17
PL - Polonia 16
EC - Ecuador 14
ES - Italia 14
IQ - Iraq 13
UA - Ucraina 13
CO - Colombia 12
NL - Olanda 11
ZA - Sudafrica 11
IE - Irlanda 10
MA - Marocco 10
ID - Indonesia 9
UZ - Uzbekistan 9
EG - Egitto 8
SA - Arabia Saudita 8
VE - Venezuela 7
CZ - Repubblica Ceca 6
KE - Kenya 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
UY - Uruguay 5
BO - Bolivia 4
CL - Cile 4
IR - Iran 4
JO - Giordania 4
LT - Lituania 4
SV - El Salvador 4
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
KZ - Kazakistan 3
MD - Moldavia 3
MY - Malesia 3
NG - Nigeria 3
PH - Filippine 3
TN - Tunisia 3
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
IL - Israele 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
CD - Congo 1
ET - Etiopia 1
GQ - Guinea Equatoriale 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MZ - Mozambico 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
Totale 8.820
Città #
Ashburn 514
Singapore 406
Fairfield 389
Hong Kong 385
Woodbridge 318
Santa Clara 302
Chandler 244
Dallas 223
Ann Arbor 220
Milan 213
Houston 193
Seattle 177
Shanghai 157
Cambridge 151
Beijing 144
Wilmington 139
Sofia 136
Serra 132
Hefei 108
New York 99
Boardman 88
Los Angeles 82
Princeton 65
Seoul 62
Pisa 61
Boulder 56
Lawrence 55
Florence 52
Vienna 48
Medford 43
Ottawa 43
Munich 41
Istanbul 35
Ho Chi Minh City 34
Dakar 33
London 33
Buffalo 31
Des Moines 29
Redondo Beach 29
Dong Ket 26
Bremen 25
Frankfurt am Main 25
Izmir 25
Marseille 24
Somma Lombardo 24
Tokyo 24
Abidjan 23
Council Bluffs 23
Hanoi 22
Pune 22
Rome 21
San Diego 21
São Paulo 21
Nanjing 20
Brussels 18
Lappeenranta 17
Lahore 16
Belo Horizonte 15
Paris 15
Turku 15
Stockholm 14
Warsaw 14
Chicago 13
Fuzhou 13
Helsinki 13
Kent 12
Nuremberg 12
Jacksonville 11
Ogden 11
Hyderabad 10
Kunming 10
Nanchang 10
Shenyang 10
Brasília 9
Campinas 9
Guangzhou 9
Haiphong 9
Massa 9
Redwood City 9
Tashkent 9
Xian 9
Lucca 8
Norwalk 8
The Dalles 8
Curitiba 7
Hebei 7
Jinan 7
Phoenix 7
Quanzhou 7
Rio de Janeiro 7
Cairo 6
Changsha 6
Dhaka 6
Dublin 6
Fortaleza 6
Las Vegas 6
Livorno 6
Manaus 6
Mexico City 6
Mogi das Cruzes 6
Totale 6.363
Nome #
The ESX-5 Associated eccB-eccC Locus Is Essential for Mycobacterium tuberculosis Viability 262
A CRISPR/Cas9-based strategy to simultaneously inactivate the entire ALS gene family in Candida orthopsilosis 228
Detection of Biofilms in Biopsies from Chronic Rhinosinusitis Patients: In Vitro Biofilm Forming Ability and Antimicrobial Susceptibility Testing in Biofilm Mode of Growth of Isolated Bacteria 204
Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters 196
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 191
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 183
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. 182
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia 178
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 178
Isolation and characterization of novel Staphylococcus aureus bacteriophage Hesat from dairy origin 171
Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus 170
Generation of virus like particles for epizootic hemorrhagic disease virus 168
Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents 167
Antimicrobial peptides: promising molecules for the treatment of biofilm-associated infections. 164
Strong Immunogenicity and Cross-Reactivity of Mycobacterium tuberculosis ESX-5 Type VII Secretion -Encoded PE-PPE Proteins Predicts Vaccine Potential 160
Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains 159
BaAMPs: The database of biofilm-active antimicrobial peptides 153
In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells 153
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages 147
A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape 143
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 142
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 141
Application of Phage Therapy in a Case of a Chronic Hip-Prosthetic Joint Infection due to Pseudomonas aeruginosa: An Italian Real-Life Experience and In Vitro Analysis 138
In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute 132
Nanoscale protein diffusion by STED-based pair correlation analysis 132
Daptomycin-loaded biodegradable thermosensitive hydrogels enhance drug stability and foster bactericidal activity against Staphylococcus aureus 128
Real-time assessment of bacteriophage T3-derived antimicrobial activity against planktonic and biofilm-embedded Escherichia coli by isothermal microcalorimetry 127
Combining antioxidant hydrogels with self-assembled microparticles for multifunctional wound dressings 126
Antimicrobial peptides for the control of biofilm formation 125
Generazione di Virus Like Particles per il virus della malattia emorragica epizootica del cervo 123
Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization 123
Genetic manipulation as a tool to unravel Candida parapsilosis species complex virulence and drug resistance: state of the art 122
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 120
Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms 118
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 118
Phage-Based Control of Methicillin Resistant Staphylococcus aureus in a Galleria mellonella Model of Implant-Associated Infection 117
Real-Time Antimicrobial Susceptibility Assay of Planktonic and Biofilm Bacteria by Isothermal Microcalorimetry 116
Biosensing systems for the detection and quantification of methane gas 115
Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis 114
Bio-Orthogonal Chemistry and Reloadable Biomaterial Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments against Staphylococcus aureus Infections 113
Diffusion Tensor Analysis by Two-Dimensional Pair Correlation of Fluorescence Fluctuations in Cells 113
Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa 112
Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm 112
Electro-responsive graphene oxide hydrogels for skin bandages: The outcome of gelatin and trypsin immobilization 111
Planktonic and biofilm-associated Pseudomonas aeruginosa and Staphylococcus epidermidis elicit differential human peripheral blood cell responses 111
Synergistic antibiotic activity against planktonic and biofilmembedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis 110
Thermogenic characterization and antifungal susceptibility of candida auris by microcalorimetry 110
In silico design of antimicrobial peptides 109
Isothermal microcalorimetry detects the presence of persister cells in a Staphylococcus aureus biofilm after vancomycin treatment 109
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 108
Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2 107
Antibacterial Efficacy of Two Commercially Available Bacteriophage Formulations, Staphylococcal Bacteriophage and PYO Bacteriophage, Against Methicillin-Resistant Staphylococcus aureus: Prevention and Eradication of Biofilm Formation and Control of a Systemic Infection of Galleria mellonella Larvae 107
Mycobacteriophages and Their Applications 102
Clinical efficacy of amoxicillin/clavulanate plus cefditoren as de-escalation combination therapy for endocarditis due to strongly biofilm-forming Enterococcus faecalis 100
Treatment of microbial biofilms in the post-antibiotic era: Prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools 98
Bacteriophage therapy as a treatment strategy for orthopaedic-device-related infections: Where do we stand? 98
In vitro antimicrobial activity against Abiotrophia defectiva and Granulicatella elegans biofilms 97
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study 95
Discovery of 2-phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 95
Comparison of sonication with chemical biofilm dislodgement methods using chelating and reducing agents: Implications for the microbiological diagnosis of implant associated infection 91
Development of Effective Antibacterial Treatment: Lessons from the Past and Novel Approaches 88
Characterization, Antibiofilm, and Depolymerizing Activity of Two Phages Active on Carbapenem-Resistant Acinetobacter baumannii 85
Isolation, Characterization, Genome Analysis and Host Resistance Development of Two Novel Lastavirus Phages Active against Pandrug-Resistant Klebsiella pneumoniae 84
Antimicrobial and Antibiofilm Activity of Auranofin and Its Two Derivatives Bearing Naproxen and Acetylcysteine as Ligands Against Staphylococci 83
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections 80
Titanium coating with mussel inspired polymer and bio-orthogonal chemistry enhances antimicrobial activity against Staphylococcus aureus 76
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 72
Infective Endocarditis Associated with Implantable Cardiac Device by Metallo-β-Lactamase-Producing Pseudomonas aeruginosa, Successfully Treated with Source Control and Cefiderocol Plus Imipenem 71
Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases 70
null 57
Evaluating the Efficiency of Chitosan‐Graphene Oxide Hybrid Hydrogels as Drug Delivery Systems 42
Defeating antibiotic-resistant bacteria with protein-resistant polyGGE film 27
Human serum lipids affect Staphylococcus aureus sensitivity to phage infection 24
Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution 24
Natural Biomolecules and Light: Antimicrobial Photodynamic Strategies in the Fight Against Antibiotic Resistance 19
Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis 14
Anti‐Pseudomonas Aeruginosa Bacteriophage Loaded Electrospun Fibers for Antibacterial Wound Dressings 13
Enhanced anti-P. aeruginosa treatment via phage and ciprofloxacin co-loaded particles prepared by electrospraying 10
null 3
null 1
Totale 9.085
Categoria #
all - tutte 27.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021379 0 0 0 0 0 29 52 47 53 57 64 77
2021/2022580 15 24 14 14 107 89 17 17 53 27 45 158
2022/2023875 112 120 75 94 76 93 4 57 160 4 60 20
2023/2024777 65 70 103 64 115 118 30 20 24 21 55 92
2024/20252.339 10 76 37 122 203 247 255 93 224 284 336 452
2025/20261.965 249 341 372 411 347 245 0 0 0 0 0 0
Totale 9.085